Skip to main content


Latest articles

27-01-2022 | Diabetes | News | Article

CVD risk tools equally inaccurate for individual prediction in type 2 diabetes

Researchers assessing 22 predictive models of cardiovascular disease risk find that none accurately predict its occurrence in a population of people with type 2 diabetes.

26-01-2022 | Diabetes | News | Article

Personal beliefs may underlie persistent hypoglycemia in CGM users

Individuals with type 1 diabetes continue to experience severe and level 2 hypoglycemia despite the use of continuous glucose monitoring systems, with the risk potentially influenced by personal beliefs, US research shows.

25-01-2022 | Diabetes | News | Article

Shift toward specialist care for type 2 diabetes

UK researchers find people with type 2 diabetes are increasingly being cared for in specialist settings, rather than by family doctors.

24-01-2022 | Diabetes | News | Article

BMI shows linear association with type 2 diabetes risk

BMI has a strong positive linear association with type 2 diabetes risk that generally does not vary by global region or ethnicity, show results of a dose-response meta-analysis.

21-01-2022 | Diabetes | News | Article

Mortality threat receding in most high-income countries for people with diabetes

Mortality in people with diabetes is declining in most high-income countries, in many cases faster than in people without diabetes, researchers report.

20-01-2022 | Diabetes | News | Article

No impact of diabetes, glycemic control on COVID-19 vaccine response

Findings from the COVAC-DM study suggest that people with type 1 or type 2 diabetes have an antibody response to COVID-19 vaccination that is similar to healthy individuals, with no association between glycemic control and antibody levels.

19-01-2022 | Diabetes | News | Article

Closed-loop benefits differ with high or low baseline HbA1c

Researchers find that the type of benefits people with type 1 diabetes gain from hybrid closed-loop insulin delivery differs according to their baseline glycemic control.

18-01-2022 | Diabetes | News | Article

Real-world data support HAPO link between LGA and raised maternal glycemia

Real-world data from Canada show that increasing maternal glycemia is associated with rising rates of large for gestational age births, confirming the results of the landmark HAPO trial.

14-01-2022 | Diabetes | News | Article

Intensive glycemic control may prevent diabetic foot ulcers

Early intensive glycemic control may reduce the long-term risk for foot ulcers in people with type 1 diabetes, suggest data from the Diabetes Control and Complications Trial and Epidemiology of Diabetes Interventions and Complications study.

13-01-2022 | Diabetes | News | Article

Residual cardiorenal risk high after SGLT2 inhibitor initiation in diabetic CKD

People with type 2 diabetes and chronic kidney disease have a high residual risk for cardiorenal events and high rates of treatment failure after initiation of SGLT2 inhibitors, real-world study findings indicate.

11-01-2022 | Diabetes | News | Article

STEP 8: Semaglutide better than liraglutide at weight-management doses

Semaglutide 2.4 mg produces substantially more weight loss than liraglutide 3.0 mg in people with overweight or obesity but without diabetes, say the STEP 8 investigators.

10-01-2022 | Diabetes | News | Article

Any structured glucose monitoring pays dividends in type 2 diabetes

Structured monitoring of blood glucose improves its control regardless of the device used, although continuous glucose monitoring is better than self-monitored blood glucose for reducing hypoglycemia, shows a randomized trial.

10-01-2022 | Diabetes | News | Article

COVID-19 vaccination may lead to temporary changes in glucose control

The proportion of on-target interstitial glucose values falls during the week following initial COVID-19 vaccination in people with type 1 diabetes, study findings indicate.

06-01-2022 | Diabetes | News | Article

Genetic study backs role for liver fat, pancreatic volume in type 2 diabetes risk

A genetic propensity for increased liver fat and lower pancreatic volume is associated with an increased risk for type 2 diabetes, say researchers.

21-12-2021 | Diabetes | News | Article

Sticking to daytime eating could combat glucose dysregulation in shift-workers

Keeping meals to their usual daytime slots may help prevent glucose dysregulation in night-shift workers, research shows.

20-12-2021 | Diabetes | News | Article

Family history of type 2 diabetes may signify increased complication risk in type 1 diabetes

Having first-degree relatives with type 2 diabetes may be associated with an increased risk for cardiovascular disease and microvascular complications among people with type 1 diabetes, particularly those diagnosed at a young age, study findings suggest.

17-12-2021 | Diabetes | News | Article

Metformin, but not sulfonylurea, may reduce poor outcome risk post HHF

Initiating metformin following hospitalization for heart failure may reduce the risk for death or further HHF in older people with comorbid diabetes, but only if they have a preserved ejection fraction, study findings indicate.

16-12-2021 | Diabetes | News | Article

Study highlights continued suboptimal glycemic control in type 1 diabetes

An update from an international study has shown that although glycemic control has improved with time among people with type 1 diabetes, it remains suboptimal and continues to vary substantially by country, age group, and data source.

15-12-2021 | Diabetes | News | Article

Simple CGM metric predicts progression to type 1 diabetes in high-risk children

Children with islet autoantibodies who spend more than 10% of their time with hyperglycemic glucose levels are highly likely to progress to clinical diabetes within the next year, show findings from the ASK study.

14-12-2021 | Diabetes | News | Article

Older age ‘not a barrier’ to closed-loop insulin delivery for type 1 diabetes

Findings from the ORACL trial suggest that closed-loop insulin delivery results in better glycemic control than sensor-augmented pump therapy among older adults with longstanding type 1 diabetes.